Navigation Links
Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours
Date:8/11/2009

KENILWORTH, N.J., Aug. 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced the launch of CLARITIN Eye, an antihistamine eye drop strong enough to control itchy eyes all day or all night. Found in the eye care aisle wherever over-the-counter products are sold, CLARITIN Eye works in minutes to relieve the itch of allergy eyes for up to 12 hours with just one drop.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/claritin/39444/

(Photo: http://www.newscom.com/cgi-bin/prnh/20090811/NY59751 )

"Itchy eyes are an extremely bothersome symptom for allergy sufferers and can be caused by indoor or outdoor allergens such as dust, pet dander, mold or pollen. CLARITIN Eye relieves the itch at the source by blocking the histamine that causes itchy eyes," said Dr. John O'Mullane, group vice president, research and development, Schering-Plough Consumer Health Care. "We're excited to add this new allergy eye product to the line of non-drowsy CLARITIN allergy products."

To support the introduction of the new product, the makers of CLARITIN will kick off the launch with national advertising as well as launching the brand's first official Facebook page. The page features a "CLARITIN Eye Makeover" application where fans are invited to upload their favorite photos and use the application to clear the red eye in their pictures. The page, available at facebook.com/claritineye, offers resources for allergy sufferers including facts, tips and a photo gallery where visitors can show how they "Live Claritin Clear(R)."

Like all non-drowsy CLARITIN products, new CLARITIN Eye is available without a prescription and can be found in most food, drug or mass retailers. CLARITIN Eye drops are located in the eye care aisle and is safe and effective for adults and children as young as three when used as directed. For more information on allergies and non-drowsy treatment options, visit CLARITIN.com.

About CLARITIN(R)

All CLARITIN brand products are non-drowsy and available without a prescription. CLARITIN provides powerful, 24-hour allergy relief and comes in a variety of forms, including: CLARITIN(R) Tablets, CLARITIN(R) Liqui-Gels(R), an easy-to-swallow liquid-filled capsule, and CLARITIN(R) RediTabs(R), a quickly dissolving tablet for ages 6 and older. In addition, CLARITIN(R) 12-Hour RediTabs(R) provide the flexibility to manage allergy symptoms all day or all night. CLARITIN-D(R) is available behind-the-counter in 12 or 24-hour extended release tablets and also includes the decongestant pseudoephedrine for powerful nasal congestion relief. CHILDREN'S CLARITIN (R) comes in great-tasting Grape Chewables or Syrup forms and is safe and effective for kids 2 and older when used as directed.

Finally, CLARITIN Eye is an antihistamine eye drop found in the eye care aisle that works in minutes and relieves the itch of allergy eyes for up to 12 hours.

CLARITIN is the No. 1 physician-recommended and pediatrician-recommended non-drowsy over-the-counter allergy brand. The CLARITIN Rx-to-OTC switch in 2002 was the largest switch ever - and the first and only for a non-drowsy antihistamine. For more information on allergies and treatment, visit www.CLARITIN.com.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning
2. Photos: Americas Chronically Ill Children Have New Hope with Hot Gift
3. Photos: Drink Wine and Live Longer - 1907 Madiran and Plaimont Wines of Southwest France Sponsor the Launch of The Red Wine Diet
4. Photos: Niavin Corporation Offers Pain Sufferers a New Way to Address Pain
5. Photos: Compact Barbell System With Flat, Streamlined Profile Travels Easily and Stores Conveniently
6. Photos: New Smoking Prevention Program Launched in Schools
7. Photos: New Kind of Health Care Reform Brings Five-Star Hospitality to Hospital Care
8. Photos: Los Angeles Non Profit Teams With US Troops Stationed in Baghdad and Buaytha in Bringing a 5-Year-Old Blind Iraqi Girl, Whose Father Stands Beside US Combat Team Against Al Qaeda, to the US for a Groundbreaking Artificial Corneal Transplant Surger
9. Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs
10. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
11. Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alexs Lemonade Stand Foundation Join facebook(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. ... , Medical doctors and PhD scientists will speak to the press on behalf of ... support of an independent vaccine safety commission. , WHERE: , Zenger Room, National ...
(Date:3/28/2017)... ... 28, 2017 , ... The Radiology Business Management Association (RBMA) is ... its new executive director. Mr. Still was selected through a careful months-long search by ... he is known to our members, has been a part of building the RBMA ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group ... serving as new board chair for Orange County health care system CalOptima Friday. ... of soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... STRASBOURG, France and TEL AVIV, Israel ... opening a subsidiary in Israel . This new ... , will be mostly dedicated to research and development of novel ... Emosis Ltd will also, when relevant, locally support commercialization and sales ... ...
(Date:3/28/2017)...  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical ... other unmet medical needs, announced today two poster ... annual meeting.  The first poster to be presented ... ENMD-2076 in Combination with Anti-PD1 in Syngeneic Cancer ... presented on April 4 is entitled " Kinase ...
(Date:3/28/2017)... The global flow cytometry ... by 2025, according to a new study by Grand ... and cancer is expected to upsurge the demand for ... coming years. In addition, higher number of physicians is ... cell therapy, due to adverse effects caused by chemotherapy ...
Breaking Medicine Technology: